New evidence on TAVI from PCR Companions

Session comprising selected EuroPCR 2024 Abstract submissions

Facilitators: P.N. Rudzinski, H. Treede
SHOW MORE

Summary

This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable TAVI bioprosthesis. Discussions will provide insights into optimizing TAVI procedures and patient management.

Presentations available when logged in:

  • Device success in valve-in-valve TAVI: comparison of SEV and BEV and bioprosthetic valve fracturing
  • Next-day discharge after TAVI
  • Comparative network meta-analysis of PCI strategies in patients undergoing TAVI
  • Thrombosis after TAVR: factors associated with response to treatment
  • Higher rates of in-hospital mortality after urgent than elective TAVI
  • Immediate and early outcomes of a novel balloon-expandable transcatheter aortic valve bio prosthesis
  • Predictors of pacemaker implantation in bicuspid aortic valve after TAVR